Department of Surgery, University of Colorado, Aurora, Colorado.
Department of Surgery, Denver Health Medical Center, Denver, Colorado.
Shock. 2018 Dec;50(6):671-676. doi: 10.1097/SHK.0000000000001089.
The balance of fibrinolytic mediators is crucial to the survival of the critically ill patient, with tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) playing significant roles. While elevated levels of PAI-1 are associated with increased morbidity and mortality, the source of this PAI-1 remains elusive. Platelets contain 90% of circulating plasma PAI-1, however, their ability to release active PAI-1 is controversial. We hypothesize platelets contain active PAI-1 in α-granules capable of immediate degranulation when exposed to high concentrations of thrombin.
In vitro apheresis platelets were stimulated with thrombin (1 IU/mL, 5 IU/mL) followed by the collection of supernatant (5-120 min). Supernatant and lysate PAI-1 was measured by ELISA. The experiment was repeated in the presence of t-PA followed by measurement of t-PA:PAI-1 complex measurement by ELISA. Finally, healthy whole blood underwent dilution with control and thrombin-treated platelet lysate followed by thrombelastography (TEG) in a t-PA-stimulated TEG.
Thrombin provoked immediate near-complete degranulation of PAI-1 from α-granules (median 5m 5 IU/mL thrombin 125.1 ng/mL, 1 IU/mL thrombin 114.9 ng/mL, control 9.9 ng/mL). The released PAI-1 rapidly complexed with t-PA, with a 4-fold increase in complex formation in the thrombin-treated supernatant. Conversely, PAI-1 in the control lysate demonstrated a 6-fold increase in complex formation compared with thrombin lysate. Last, control platelet lysate inhibited t-PA-induced fibrinolysis by TEG (median LY30 control 15m 7.9%), while thrombin-treated platelet lysates, after PAI-1 degranulation, were unable to affect the fibrinolysis profile (median LY30 5 IU/mL 28.5%, 1 IU/mL 12.4%).
Thrombin provokes rapid α-degranulation of active PAI-1, capable of complexing with t-PA and neutralizing t-PA-induced fibrinolysis by TEG.
纤维蛋白溶解介质的平衡对危重病患者的生存至关重要,组织型纤溶酶原激活物(t-PA)和纤溶酶原激活物抑制剂-1(PAI-1)起着重要作用。虽然 PAI-1 水平升高与发病率和死亡率增加有关,但这种 PAI-1 的来源仍不清楚。血小板含有循环血浆 PAI-1 的 90%,然而,它们释放有活性的 PAI-1 的能力存在争议。我们假设血小板在α-颗粒中含有有活性的 PAI-1,当暴露于高浓度的凝血酶时,这些 PAI-1 能够立即脱颗粒。
用凝血酶(1IU/mL,5IU/mL)刺激体外分离的血小板,然后收集上清液(5-120 分钟)。通过 ELISA 测量上清液和裂解物中的 PAI-1。在 t-PA 存在的情况下重复该实验,然后通过 ELISA 测量 t-PA:PAI-1 复合物的测量。最后,用对照和凝血酶处理的血小板裂解物稀释健康全血,然后在 t-PA 刺激的血栓弹力图(TEG)中进行 TEG。
凝血酶迅速引发了 PAI-1 从α-颗粒的几乎完全脱颗粒(中位数 5m 5IU/mL 凝血酶 125.1ng/mL,1IU/mL 凝血酶 114.9ng/mL,对照 9.9ng/mL)。释放的 PAI-1 迅速与 t-PA 形成复合物,在凝血酶处理的上清液中复合物形成增加了 4 倍。相反,对照裂解物中的 PAI-1 与凝血酶裂解物相比,复合物形成增加了 6 倍。最后,对照血小板裂解物通过 TEG 抑制 t-PA 诱导的纤维蛋白溶解(中位数 LY30 对照 15m 7.9%),而在 PAI-1 脱颗粒后,凝血酶处理的血小板裂解物无法影响纤维蛋白溶解谱(中位数 LY30 5IU/mL 28.5%,1IU/mL 12.4%)。
凝血酶迅速引发有活性的 PAI-1 的α-脱颗粒,能够与 t-PA 形成复合物,并通过 TEG 中和 t-PA 诱导的纤维蛋白溶解。